Henan Newland Pharmaceutical Co. Ltd. A (301277) — Financial Flexibility Index
Henan Newland Pharmaceutical Co. Ltd. A (301277) has a Financial Flexibility Index of 0.96x as of December 2025. Free cash flow of CN¥218.32 Million (operating CF CN¥116.94 Million minus capex CN¥101.38 Million) represents 1% of total liabilities (CN¥228.49 Million). Check Henan Newland Pharmaceutical Co. Ltd. A total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Henan Newland Pharmaceutical Co. Ltd. A Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Henan Newland Pharmaceutical Co. Ltd. A across 6 annual periods. For the full cash flow conversion analysis, see Henan Newland Pharmaceutical Co. Ltd. A operating cash flow efficiency.
Annual Financial Flexibility Index for Henan Newland Pharmaceutical Co. Ltd. A (2020–2025)
Year-by-year free cash flow to debt coverage for Henan Newland Pharmaceutical Co. Ltd. A. Explore cash flow to debt ratio of Henan Newland Pharmaceutical Co. Ltd. A to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.96x | CN¥218.32 Million | CN¥116.94 Million | CN¥228.49 Million | ▲ +8.9% |
| 2024 | 0.88x | CN¥237.55 Million | CN¥126.76 Million | CN¥270.69 Million | ▼ -60.6% |
| 2023 | 2.22x | CN¥355.97 Million | CN¥259.46 Million | CN¥160.02 Million | ▲ +147.1% |
| 2022 | 0.90x | CN¥157.19 Million | CN¥82.85 Million | CN¥174.58 Million | ▲ +216.2% |
| 2021 | 0.28x | CN¥74.48 Million | CN¥49.08 Million | CN¥261.53 Million | ▼ -8.4% |
| 2020 | 0.31x | CN¥64.82 Million | CN¥47.86 Million | CN¥208.57 Million | — |